failure to thrive for investigators · failure to thrive for investigators author: petska, hlilary...
TRANSCRIPT
3/20/2020
1
WI CAN Educational Series
Hillary W. Petska, MD, MPHChild Advocacy and Protection Services
Children’s Hospital of Wisconsin
Matthew Torbenson, JDDeputy District Attorney
Milwaukee County
3/20/20
• Review the epidemiology of pediatric poisonings.
• Recognize that ingestions in children are not always accidental.
• Describe the importance of investigation in cases of suspected poisoning.
1
2
3/20/2020
2
• Exposures in the US• >300 kids/d treated in
ED
• 2 kids/d die
• Accidental >> intentional poisoning
• 610 “malicious” exposures/yr
CDC 2019, Gummin 2019, Yin 2010, 2011
• Top 5 Therapeutic Errors
1. Given med twice
2. Incorrect dose
3. Wrong med given
4. Meds given too close together
5. Confused units of measure
Gummin 2019
3
4
3/20/2020
3
• N = 928 children
• 94% witnessed or suspected ingestion
• 13% evaluated by CPT
• 4% referred to CPS
W ood 2012
• Unintentional ingestion
• Momentary lapse of supervision
• Drug exposure during breastfeeding
• Neglect
• Supervisory neglect
• Dangerous environment
5
6
3/20/2020
4
• Intentional ingestion• Self-inflicted
• Recreational use
• Suicide attempt
• Inflicted by another• Caregiver under
influence gives wrong med
• Drug given to decrease
responsiveness
• Inflict harm or gain
attention (medical child abuse)
Reece 2009, Gummin 2019
• Peak age group = 1-2 yo
• Substances 1. Cosmetics/personal
care products
2. Household cleaning substances
3. Analgesics
4. Foreign bodies/toys
5. Topical preparations
• Medical attention < 2 hrs
7
8
3/20/2020
5
Reece 2009, I llingworth 1994
• Age < 1 yo• <5 mos
• Extrusor ref lex
• 9 mos:• Crawling
• Pincer grasp
• Self-feeding
• 12-18 mos:• Walking
• Substance• Low dose if noxious
• Illicit
All Exposures1 Malicious Exposures2
1. Analgesics 1. Analgesics
2. Topical preparations 2. Stimulants/street drugs
3. Antihistamines 3. Sedatives/hypnotics/antipsychotics
4. Vitamins 4. Cold/cough preparations
5. Dietary supplements/ herbals/homeopathic
5. Unknown drug
6. GI preparations 6. Ethanol
7. Antimicrobials 7. Topical preparations
8. Cardiovascular drugs 8. GI preparations
9. Cold/cough preparations 9. Antihistamines
10. Electrolytes and minerals 10. Antidepressants1Gummin 2019 2Yin 2010
9
10
3/20/2020
6
Reece 2009
• Presentation• Unexplained seizures or
life-threatening events
• Death w/o obvious cause
• Chronic unexplained symptoms (~MCA)
• Other evidence of maltreatment
• History• No or changing• Not c/w child’s
development
• Delay in seeking care
• Chief Complaint• Witnessed/suspected
ingestion
• Unexplained symptoms/ altered mental status
• Recurrent unexplained illness or symptoms (overlap with MCA)
• Child fatality
• Incidental finding on drug screening
11
12
3/20/2020
7
• Complete medical history
• All drugs/meds in the home
• Symptoms
• Development
• Discipline
• Interview child if possible
Symptoms Possible causative agents
Hallucinations Atropine-like agents
Bizarre movements Phenothiazines, metoclopramide, antihistamines
Diarrhea Laxatives, salt, ipecac, furosemide, caffeine, iron
Vomit Arsenic, ipecac, furosemide, cooking oil, ethylene glycol, caffeine, iron
Bloody vomit Iron, salicylates
Extreme thirst Salt +/- water deprivation
Bizarre lab results Insulin, salt, salicylates, sodium bicarbonate
Mouth burns/ulcers Lye, muriatic acid, tabasco sauce, peppers
Sweating Cocaine, nicotine, amphetamines
Fever Amphetamines, salicylates, phenothiazines, tricyclic antidepressants, cocaine, vitamin A overdose
Failure to thrive Water deprivation or intoxication, laxatives, phenytoin, ipecac, salt
Seizures/apnea Salt, phenothiazines, tricyclic antidepressants, hydrocarbons, barbiturates, ethanol, codeine
Drowsiness/sedation Benzodiazepines, opioids/opiates, hypnotics, insulin, anticonvulsants, methadone, marijuana
M eadow 1989, Paschall 2005
13
14
3/20/2020
8
• Sympathomimetic (meth, amphetamines, cocaine, opiate withdrawal, PCP)
• Hyperthermia (increased body temperature), tachycardia (increased heart rate), hypertension (increased blood pressure), mydriasis (dilation of the pupil), warm/moist skin, agitation
• Cholinergic (organophosphates, betel nut, VX, Soman, Sarin) • SLUDGE (Salivation, Lacrimation, Urinary incontinence,
Diarrhea/Diaphoresis, GI upset/hyperactive bowel, Emesis)
• Anticholinergic (antihistamines, atropine, phenothiazines, TCA)
• Hyperthermia, tachycardia, hypertension, hot/red/dry skin, mydriasis or unreactive pupils, urinary retention, absent bowel sounds
• Opioids (codeine, dextromethorphan, heroin) • Miosis (constriction of the pupil), respiratory depression, sedation
Toce 2017
15
16
3/20/2020
9
• Labs
• Glucose
• Electrolytes
• Drug test
• Imaging
• KUB
• Consults• Toxicology
• Child Advocacy
• Substrate• Blood
• Urine
• Test method• ER drug screen
• Comprehensive drug panel
• Limitations
17
18
3/20/2020
10
Moeller 2008
ER Drug Screen Urine Drug Investigation
Substances Detected 6 >140
Threshold Workplace (high) <<Workplace (low)
Amount of Urine 1 – 5 ml 1 – 6 ml
Time to Result <2 hours 3-5 days
Confirmation No Yes
Methodology Immunoassay GC-MS or LC-tandem MS
Sensitivity and Specificity Low High
Charge $900 $361
19
20
3/20/2020
11
Substances on standard drug
screens
Cross-reacting substances
Amphetamines Amantadine, buproprion, chloroquine, chlorpromazine, desipramine, dextroamphetamine, ephedrine, labetolol,
methylphenidate, phentermine, procainamide, promethazine, pseudoephedrine, ranitidine, selegiline, trazodone
Cannabinoids Dronabinol, efavirenz, NSAIDs, proton pump inhibitors
Cocaine Salicylates, topical anesthetics with cocaine
Opiates Dextromethorphan, diphenhydramine, quinolones, poppy seeds, rifampin
PCP Chlorpromazine, dextromethorphan, diphenhydramine, ibuprofen, imipramine, ketamine, meperidine, thioridazine,
tramadol, venlafaxine
Farst 2012
• DDx:• Unintentional exposure
• Supervisory neglect
• Sepsis• Meningitis
• Epilepsy
• Head trauma
• Apnea
• ALTE/BRUE
• SIDS• Metabolic derangements
• Bleeding diatheses
• Gastroenteritis
Reece 2009
21
22
3/20/2020
12
Initial Investigation Scene (body if deceased)
Witnesses
Medical Hospital (Child Advocacy or Medical Examiner if
deceased)
Medical History – past medical records (see Wis. Stat. §146.82(11))
Investigation + Medical Evidence = Complete Picture
Confrontation Interviews
Confrontation Evidence
The Initial Investigation
Scene
Preservation of the scene
Documentation of the scene
Collection/Preservation of physical evidence
Witnesses
Detailed non-confrontational statements with caregiver(s)
Detailed account of child’s last 24,48,72, 96 hours…
Child Protective Services – Wis. Stat. § 48.981(7)(a)8
Re-enactments (recorded if possible)
23
24
3/20/2020
13
The Scene:
Document the entire scene
Photos and/or video
Document the condition of the home, including ANY safety concerns
Drugs/alcohol & weapons
Unkempt home
If caretaker provide accidental explanation for injury:
Document circumstances in detail
Do re-enactment if possible (on video)
The Scene:
Always collect the last bottle/cup used for a feeding
Document any prescribed medication/pills
When was the prescription filled last?
How often is the person supposed to take the medication?
Do all of the pills inside the container match?
Are there more than one prescription from different doctors?
Was the medication properly secured?
25
26
3/20/2020
14
Caregiver(s) Statements:
Lock them in!!!
Household information – who is home & when
When was child last normal?
When was child last fed? *** Any issues with last feeding(s) ***
Any recent concerns with child’s health?
Child’s developmental capabilities
Who found the child?
When was care sought? (anyone else sought care prior?)
Accidental explanation
Re-creation on video
Caregiver(s) Statements – Initial Statements
Develop a timeline (up to 96 hours) Non-accusatory
Non-confrontational
Go over events more than one time
Never interview caretakers together
Compare with statements of witnesses Forensic interviews of child witness(es)
27
28
3/20/2020
15
Confrontation Interviews – get detailed timeline to start. Then…
Inconsistencies in statements
Inconsistencies with witness accounts
Inconsistencies with the physical evidence
Inconsistencies with the medical evidence
Embrace the evolving history of the offender
Offender keeps trying to change the events to account for the severity of the injuries
Confrontation Interviews:
Delays in seeking treatment (just as valuable!) Description of child’s condition during delay is
critical – knowledge
If you get an admission…. It doesn’t end there!
Re-enactment on video
Share re-enactment with medical professionals –does it explain the injuries?
If not, you are not done!
29
30
3/20/2020
16
Medical Evidence + Thorough Investigation = TRUTH
• Not all ingestions are accidental.
• Identification requires a high index of suspicion.
• The right drug test can help.
• Investigation is crucial.
31
32
3/20/2020
17
• Dine MS, McGovern ME. Intentional poisoning of children–an overlooked category of child abuse: Report of seven cases and review of the literature. Pediatrics. 70(1):32–35;1982.
• Farst K, BB Bolden. Substance-exposed infants and children: forensic approach. Clin Pediatr EmergMed. 13(3): 221-8;2012.
• Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, et al. 2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019 Dec;57(12):1220-1413.
• Henretig FM, Paschall R, Donaruma-KwohMM. Child abuse by poisoning. In: Child Abuse Medical Diagnosis & Management, 3rd ed, Reece R, Christian C (Eds), American Academy of Pediatrics, Elk Grove Village, IL;2009.
• Meadow R. ABC of child abuse. Poisoning. BMJ. 298(6685):1445-1446;1989.
• Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 83(1):66-76;2008.
• Paschall R. The chemically abused child. In Child Maltreatment, Giardino A, Alexander R (Eds.), G.W. Medical Publishing, St. Louis, MO;2005.
• Toce MS, Burns MM. The poisoned pediatric patient. Pediatr Rev. 38(5):207-220;2017.
• Yin S. Malicious use of nonpharmaceuticals in children. Child Abuse Negl. 35(11):924-929;2011.
• Yin S. Malicious use of pharmaceuticals in children. J Pediatr. 157(5):832-6; 2010.
• Thank you to Dr. Lynn Sheets for additional slide content.
33
34